In this section
Anaesthesia makes up the largest hospital speciality and has a huge role to play in nearly every aspect of any hospital from operating theatres to accident and emergency, to the labour ward, and to intensive care. Our research ranges from basic molecular research into mechanisms of anaesthesia to investigating the clinical impact of novel anaesthetic agents.
Our research covers the entirety of patient’s perioperative journey and through this, we aim to deliver the greatest impact. The section has been pioneering in the development of novel technologies to facilitate the delivery of anaesthetic agents and has also made pivotal in-roads into the mechanism of action of anaesthetic agents and their wider application to other diseases (such as their protective roles in brain injury and in cancer).
@inproceedings{Armstrong:2012,
author = {Armstrong, SP and Banks, P and McKitrick, T and Geldart, C and Edge, C and Babla, R and Simillis, C and Franks, NP and Dickinson, R},
title = {Mutations in the NMDA receptor glycine site prevent competitive inhibition by xenon without affecting inhibition by sevoflurane or isoflurane},
year = {2012}
}
TY - CPAPER
AU - Armstrong,SP
AU - Banks,P
AU - McKitrick,T
AU - Geldart,C
AU - Edge,C
AU - Babla,R
AU - Simillis,C
AU - Franks,NP
AU - Dickinson,R
PY - 2012///
TI - Mutations in the NMDA receptor glycine site prevent competitive inhibition by xenon without affecting inhibition by sevoflurane or isoflurane
ER -